DocGo Inc expected to post a loss of 6 cents a share - Earnings Preview
DocGo Inc expected to post a loss of 6 cents a share - Earnings Preview
DocGo Inc DCGO.OQ DCGO.O is expected to show a fall in quarterly revenue when it reports results on August 5 (estimated) for the period ending June 30 2026
The New York City-based company is expected to report a 6.2% decrease in revenue to $75.404 million from $80.42 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
LSEG's mean analyst estimate for DocGo Inc is for a loss of 6 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for DocGo Inc is $1.75, about 169% above its last closing price of $0.65
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2026 | -0.11 | -0.09 | -0.13 | Missed | -39.3 |
Dec. 31 2026 | -0.12 | -0.13 | -1.37 | Missed | -940.5 |
Sep. 30 2025 | -0.13 | -0.12 | -0.11 | Beat | 2.3 |
Jun. 30 2025 | -0.10 | -0.09 | -0.11 | Missed | -16.7 |
Mar. 31 2025 | -0.03 | -0.02 | -0.09 | Missed | -320 |
Dec. 31 2024 | 0.04 | 0.05 | 0.04 | Missed | -17.6 |
Sep. 30 2024 | 0.04 | 0.05 | 0.05 | Met | 2.9 |
Jun. 30 2024 | 0.06 | 0.08 | 0.07 | Missed | -6.7 |
This summary was machine generated August 3 at 21:02 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on DocGo
See all newsU.S. STOCKS ON THE MOVE-Gold miners, Weave Communications, Amylyx Pharmaceuticals
U.S. STOCKS ON THE MOVE-BioMarin Pharmaceutical, Home Depot, Klarna Group
U.S. STOCKS ON THE MOVE-EyePoint Inc, Amer Sports, Pliant Therapeutics
U.S. STOCKS ON THE MOVE-Dynatrace, Duolingo, Baidu Inc
DocGo slips on tepid quarterly results, narrower annual outlook